JO25567: common adverse events reported in the safety population (1/3)1

Image 27@2x.png

Data are n (%). Adverse events reported by 10% or more patients for grades 1 and 2 and all adverse events for grades 3–5

Reference

  1. Seto T, et al. Lancet Oncol 2014; 15:1236–44

JO25567: common adverse events reported in the safety population (2/3)1

Image 28@2x.png

Data are n (%). Adverse events reported by 10% or more patients for grades 1 and 2 and all adverse events for grades 3–5

Reference

  1. Seto T, et al. Lancet Oncol 2014; 15:1236–44

JO25567: common adverse events reported in the safety population (3/3)1

Image 29@2x.png

Data are n (%). Adverse events reported by 10% or more patients for grades 1 and 2 and all adverse events for grades 3–5

Reference

  1. Seto T, et al. Lancet Oncol 2014; 15:1236–44